Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€46.00

€46.00

3.600%
1.6
3.600%
€75.69
 
12.05.26 / Tradegate WKN: 881782 / Symbol: HAE / Name: Haemonetics / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Haemonetics Corp. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Haemonetics

sharewise wants to provide you with the best news and tools for Haemonetics, so we directly link to the best financial data sources.

News

Haemonetics Q4 Earnings Call Highlights
Haemonetics Q4 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported fiscal fourth-quarter revenue of $346 million, up 5% on a reported basis and 9% organically excluding CSL, as strength in its Plasma and Blood Management

What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year: https://cdn.content.foolcdn.com/images/1umn9qeh/production/d227e0f40b399dc519a5bed98ee8a4568fc6efb8-1401x1251.png?rect=76,0,1251,1251&w=384&h=384&q=75&fit=crop&auto=format
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year

Invenomic Capital Management fully exited its position in Haemonetics Corporation (NYSE:HAE), according to a February 17, 2026, SEC filing, selling 498,317 shares previously worth $24.29 million.